Project Description

STATUS: Exited

Innovative Biosensors (IBI), based in Rockville, Maryland, is a clinical stage diagnostics company that develops, manufactures, and markets rapid pathogen detection and diagnostic systems comprised of biosensors (a novel cellular based bioluminescent immunoassay) that generate results at previously unseen levels of speed, sensitivity and specificity.

New Markets Team Member:

Mark Grovic